BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3515615)

  • 1. Amidolytic assay of factor V in human plasma.
    Hägglund U; Blombäck M
    Thromb Res; 1986 Jan; 41(1):79-88. PubMed ID: 3515615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin activation by an activator from the venom of Oxyuranus scutellatus (Taipan snake).
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    J Biol Chem; 1986 Oct; 261(28):13258-67. PubMed ID: 3531198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
    Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet procoagulant properties studied with snake venom prothrombin activators.
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of human factor VII by the prothrombin activator from the venom of Oxyuranus scutellatus (Taipan snake).
    Nakagaki T; Lin P; Kisiel W
    Thromb Res; 1992 Jan; 65(1):105-16. PubMed ID: 1604437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full length nucleotide sequence of a factor V-like subunit of oscutarin from Oxyuranus scutellatus scutellatus (coastal Taipan).
    Welton RE; Burnell JN
    Toxicon; 2005 Sep; 46(3):328-36. PubMed ID: 15993914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of venom proteases on peptide chromogenic substrates and bovine prothrombin.
    Teng CM; Wang JP; Huang TF; Liau MY
    Toxicon; 1989; 27(2):161-7. PubMed ID: 2655180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.
    Scott CF; Sinha D; Seaman FS; Walsh PN; Colman RW
    Blood; 1984 Jan; 63(1):42-50. PubMed ID: 6606454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assay of factor V in plasma using a synthetic chromogenic substrate.
    Nishibe H
    Clin Chim Acta; 1980 Oct; 106(3):301-7. PubMed ID: 7418230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of coagulant antigens and inhibition of activated protein C in combined factor V VIII deficiency.
    Giddings JC; Sugrue A; Bloom AL
    Br J Haematol; 1982 Nov; 52(3):495-502. PubMed ID: 6812616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a prothrombin activator from the venom of the Australian brown snake, Pseudonaja textilis textilis.
    Masci PP; Whitaker AN; de Jersey J
    Biochem Int; 1988 Nov; 17(5):825-35. PubMed ID: 3075905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a variant of human prothrombin: prothrombin Segovia.
    Collados MT; Fernández J; Páramo JA; Montes R; Borbolla JR; Montaño LF; Rocha E
    Thromb Res; 1997 Mar; 85(6):465-77. PubMed ID: 9101639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the prothrombin activator from the venom of Oxyuranus scutellatus scutellatus (taipan venom).
    Walker FJ; Owen WG; Esmon CT
    Biochemistry; 1980 Mar; 19(5):1020-3. PubMed ID: 6986908
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromogenic substrate spectrophotometric assays for the measurement of clotting function.
    Aiyappa PA
    Ann N Y Acad Sci; 1981; 370():812-21. PubMed ID: 6943978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel fibrinogen-clotting enzyme, TL-BJ, from the venom of the snake Bothrops jararaca: purification and characterization.
    Serrano SM; Sampaio CA; Mentele R; Camargo AC; Fink E
    Thromb Haemost; 2000 Mar; 83(3):438-44. PubMed ID: 10744151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taipan viper venom and chromogenic substrate (chromozym Th). Prothrombin assay. No sensitivity to coumarin-induced prothrombin.
    Girolami A; Petrassi G; Cella G; Saltarin P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):822-30. PubMed ID: 6176507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF; Pixley RA; Colman RW
    Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.